According to filings with the U.S. Securities and Exchange Commission, Sleuth Insights, Inc. is raising up to $7,914,999.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Sleuth Insights, Inc.
100% done-for-you AI competitive intelligence platform for biopharma leaders. We provide rapid, best-in-class analysis to bespoke strategic questions >90% faster than in-house teams or consultants + ongoing monitoring to stay on top of market shifts. Sleuth is built on 100M+ curated data points and document from public and proprietary sources around the world.

To learn more about Sleuth Insights, Inc., visit https://sleuthinsights.com/
Sleuth Insights, Inc. Linkedin Page: https://www.linkedin.com/company/sleuth-insights/

Contact:
Andrew Pannu, President and Chief Executive Officer
650-550-1325
https://www.linkedin.com/in/andrewpannu/

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.